Pharmazeutische Biologie

Review Articles

  1. Heide L (2014) New aminocoumarin antibiotics as gyrase inhibitors. Microbiol 304: 31-36
  2. Heide L (2009) The aminocoumarins: biosynthesis and biology. Nat Prod Rep 26:1241-1250.
  3. Heide L (2009) Genetic engineering of antibiotic biosynthesis for the generation of new aminocoumarins. Biotechnol Adv 27: 1006-1014.
  4. Heide L (2009) Prenyl transfer to aromatic substrates: genetics and enzymology. Curr Opin Chem Biol 13: 171-179.
  5. Saleh O, Haagen Y, Seeger K, Heide L (2009) Prenyl transfer to aromatic substrates in the biosynthesis of aminocoumarins, meroterpenoids and phenazines: The ABBA prenyltransferase family. Phytochemistry 70: 1728-1738..
  6. Heide L (2009) Aminocoumarins: Mutasynthesis, chemoenzymatic synthesis and metabolic engineering. Meth Enzymol. 459: 437-455
  7. Tello M, Kuzuyama T, Heide L, P. Noel JP, Richard SB (2008) The ABBA family of aromatic prenyltransferases: broadening natural product diversity. Cell Mol Life Sci 65:1459-1463.
  8. Heide L, Gust B, Anderle C, Li S-M (2008): Combinatorial biosynthesis, metabolic engineering and mutasynthesis for the generation of new aminocoumarin antibiotics. Curr Top Med Chem 8: 667-779.
  9. Li S-M, Heide L (2006) The biosynthetic gene clusters of aminocoumarin antibiotics. Planta Med 72, 1093-1099
  10. Li S-M, Heide L (2005) New aminocoumarin antibiotics from genetically engineered Streptomyces strains. Curr Med Chem 12, 763-771
  11. Li S-M, Heide L (2004) Functional analysis of biosynthetic genes of aminocoumarins and production of hybrid antibiotics; Curr Med Chem Anti-Inf Agents 3, 279-295
  12. Biegert C, Heide L (2004) Evidenz-basierte Phytotherapie bei Schmerzen? Ein aktueller Überblick. Z Phytother. 25: 97-106
  13. Wagner I, Biegert C, Heide L (2003) Phytoanalgetika. Aktuelle Forschungsergebnisse zur Weidenrinde. Pharmazeut. Ztg. 143(13): 1153-1164
  14. Heide L, Li S-M (2002) Coumarin antibiotics. In: Fierro F, Martin JF (eds) Microbial Secondary Metabolites: Biosynthesis, Genetics and Regulation. Research Signpost, Trivandrum, India. pp. 63-83
  15. Wagner I, Heide L (2002) Bewertung klinischer Studien. In: Praxis der Arzneimittelinformation. S. Weinzierl (ed.). Govi Verlag, Eschborn, Germany. pp. 169-199.
  16. Heide L (2001) Leonhart Fuchs. Das New Kreüterbuch als Grundlage der modernen Phytotherapie. Pharmazeut. Ztg. 40, 3469-3476.
  17. Heide L, Biegert C, Wagner I (2001) Rheumatische Erkrankungen. In: Angewandte Arzneimitteltherapie. Klinisch-Pharmazeutische Betreuung in Fallbeispielen. Schneemann H, Young LY, Koda-Kimble MA (Hrg). Springer, Berlin. S. 343 – 361.
  18. Heide L (1999) Expression of the bacterial ubiC gene opens a new biosynthetic pathway in plants. In: Metabolic engineering of plant secondary metabolism (Verpoorte R and Alfermann AW, eds). Kluwer Academic Publishers, Drordrecht, The Netherlands. pp. 233-251
  19. Heide L (1998) Bio- und gentechnische Herstellung von Arzneimitteln. Dt Apoth Ztg 138, 557
  20. Heide L (1996) Phytotherapy in Germany. Its role in self-medication and in medical prescribing. Natural Medicine 50, 259-264
  21. Heide L (1994) Pharmazeutische Biologie im Blickpunkt. Pharmazie in unserer Zeit 23, 100-104
  22. Heide L (1988) Biotechnologie in Nordrhein‑Westfalen: Institut für Pharmazeu­tische Biologie der Rheinischen Friedrich‑Wilhelms‑ Universität Bonn. BioEngeneering 4, 93‑96
  23. Heide L (1987) Kampo: Traditionelle Chinesische Medizin im modernen Japan. Deutsche Apotheker‑Zeitung 127, 2072‑2076.

Privacy settings

Our website uses cookies. Some of them are mandatory, while others allow us to improve your user experience on our website. The settings you have made can be edited at any time.

or

Essential

in2code

Videos

in2code
YouTube
Google